Dren AT[au] - Search Results

Year	Number of Results
1967	1
1968	4
1976	2
1977	2
1978	2
1979	1
1982	1
1983	1
1991	1
1993	1
1996	1
2024	0

1

Does sigma receptor antagonism predict clinical antipsychotic efficacy?

Borison RL, Diamond BI, Dren AT. Borison RL, et al. Among authors: dren at. Psychopharmacol Bull. 1991;27(2):103-6. Psychopharmacol Bull. 1991. PMID: 1681560 Clinical Trial.

2

Bidirectional interaction of valproate and lamotrigine in healthy subjects.

Anderson GD, Yau MK, Gidal BE, Harris SJ, Levy RH, Lai AA, Wolf KB, Wargin WA, Dren AT. Anderson GD, et al. Among authors: dren at. Clin Pharmacol Ther. 1996 Aug;60(2):145-56. doi: 10.1016/S0009-9236(96)90130-7. Clin Pharmacol Ther. 1996. PMID: 8823232 Clinical Trial.

3

Drugs derived from cannabinoids. 2. Basic esters of nitrogen and carbocyclic analogs.

Razdan RK, Terris BZ, Pars HG, Plotnikoff NP, Dodge PW, Dren AT, Kyncl J, Somani P. Razdan RK, et al. Among authors: dren at. J Med Chem. 1976 Apr;19(4):454-61. doi: 10.1021/jm00226a002. J Med Chem. 1976. PMID: 817020

4

3-Halo-5,7-dimethylpyrazolo [1,5-a]pyrimidines, a nonbenzodiazepinoid class of antianxiety agents devoid of potentiation of central nervous system depressant effects of ethanol or barbiturates.

Kirkpatrick WE, Okabe T, Hillyard IW, Robins RK, Dren AT, Novinson T. Kirkpatrick WE, et al. Among authors: dren at. J Med Chem. 1977 Mar;20(3):386-93. doi: 10.1021/jm00213a014. J Med Chem. 1977. PMID: 15111

5

The first clinical study of BW-234U in schizophrenia.

Davidson J, Miller R, Wingfield M, Zung W, Dren AT. Davidson J, et al. Among authors: dren at. Psychopharmacol Bull. 1982 Oct;18(4):173-6. Psychopharmacol Bull. 1982. PMID: 6130560 No abstract available.

6

Placebo-controlled study of the efficacy and safety of lamotrigine in patients with partial seizures. U.S. Lamotrigine Protocol 0.5 Clinical Trial Group.

Matsuo F, Bergen D, Faught E, Messenheimer JA, Dren AT, Rudd GD, Lineberry CG. Matsuo F, et al. Among authors: dren at. Neurology. 1993 Nov;43(11):2284-91. doi: 10.1212/wnl.43.11.2284. Neurology. 1993. PMID: 8232944 Clinical Trial.

7

Role of cholinergic mechanisms in states of wakefulness and sleep.

Domino EF, Yamamoto K, Dren AT. Domino EF, et al. Among authors: dren at. Prog Brain Res. 1968;28:113-33. doi: 10.1016/S0079-6123(08)64547-1. Prog Brain Res. 1968. PMID: 5749010 No abstract available.

8

N-o-Methoxyphenylpiperazine: a simple blocker of dopaminergic receptors in the brain.

Minard FN, Cain JC, Grant DS, Dren AT. Minard FN, et al. Among authors: dren at. J Pharm Pharmacol. 1979 Feb;31(2):91-3. doi: 10.1111/j.2042-7158.1979.tb13439.x. J Pharm Pharmacol. 1979. PMID: 33259

9

Local anesthetic activity and acute toxicity of N-substituted 1,2,3,4-tetrahydro-1- and 2-naphthylamines.

Dren AT, Bopp BA, Ebert DM, Geiszler AO, Holland JB, Horrom BW, Dunnigan DA. Dren AT, et al. J Pharm Sci. 1978 Jun;67(6):880-2. doi: 10.1002/jps.2600670647. J Pharm Sci. 1978. PMID: 660483

10

Effects of physostigmine on rat brain acetylcholine, acetylcholinesterase and conditioned pole jumping.

Rosecrans JA, Dren AT, Domino EF. Rosecrans JA, et al. Among authors: dren at. Int J Neuropharmacol. 1968 Mar;7(2):127-34. doi: 10.1016/0028-3908(68)90006-3. Int J Neuropharmacol. 1968. PMID: 5710521 Free article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

17 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

17 results

Results by year